Blood Group Genotyping for Sickle Cell and Thalassaemia
Details
| Contract Title: | Blood Group Genotyping for Sickle Cell and Thalassaemia |
| Published Date: | Dec 7, 2025 |
| Notice Type: | Award (ContractAwardNotice) |
| Value Banding: | High Value |
| Delivery Point: | United Kingdom |
Description:
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping...